Compound E, chemically designated as the compound 209986-17-4, represents a significant investigation within the field of Alzheimer's illness research. This γ-secretase blocking agent was initially developed as a https://montycbmo885913.aboutyoublog.com/51565851/γ-secretase-suppressor-compound-e-209986-17-4